Amniotic Membrane Market Forecast to 2030

Amniotic Membrane Market Forecast to 2030

Market Overview
The amniotic membrane (AM), the innermost layer of the placenta, is made up of cells and tissues that act as a mechanism for soft tissue regeneration after a wound. The amniotic membrane contains biologically active cells that secrete growth factors and cytokines with anti-inflammatory, anti-immunogenic, and anti-fibrotic qualities. These cells are found in both the epithelial and stromal layers. The market is also expanding for amniotic membrane eye treatments. The amniotic membrane market study states that recent growth in tissue-based products is attributable to higher transplant rates brought on by more awareness.

The industry is expanding because of more donations brought about by increased awareness. Amniotic membranes are frequently used for a variety of conditions, including pressure and venous leg ulcers, corneal ulcers, limbal stem cell deficiency, pterygium excisions, surgical wounds, and regenerative medicine. Without a doubt, the industry will grow swiftly and consistently. The development of amniotic membrane in the field of amniotic membrane ophthalmology is also being researched and studied, as is the amniotic membrane transplantation technique that will be used in the future.

Segment Overview
The market for amniotic membranes is divided into two product categories: cryopreserved and dehydrated amniotic membrane respectively. The amniotic membrane market is segmented based on its application, which includes surgical wounds, ophthalmology, and others.

Regional Analysis
The amniotic membrane market has been divided into four regions: Asia-Pacific, North America, Europe and other countries. North America having the major share of the market and is expected to continue to do so in the coming years due to the presence of leading industry players and well-established healthcare facilities. Meanwhile, Europe is projected to have the highest growth rate and largest market share by the end of the forecast period, thanks to public funding for the healthcare system and the implementation of universal healthcare systems in several countries. The market for amniotic membrane is also expected to grow in other parts of the world. The target end-users for this market include hospitals, ambulatory surgical centers, specialty clinics, and academic and research institutions.

Major Players
Amniotic Membrane market leading companies consist of Alliqua BioMedical Inc.; Human Regenerative Technologies, LLC; Applied Biologics, LLC; DermaSciences; Amniox Medical Inc.; Amnio Technology, LLC; Skye Biologics, Inc.; MiMedx Group Inc.; and Organogensis, Inc.

COVID 19 Impacts
The market suffered from the COVID-19 pandemic. The limited capacities and resources (such as patient care specialists and hospital beds) were being reserved or redistributed toward COVID-19 patient care; therefore, elective surgeries were being refused (cancelled/postponed). Curfews and lockdowns have also been enforced in numerous countries to combat the escalating COVID-19 cases. Patients were unable to visit clinics, hospitals, or OPDs as a result of these lockdowns. This temporary ban on non-emergent healthcare services constrained the expansion of the amniotic membranes market. However, it is projected that the need for amniotic products would rise over the future years.

Companies Mentioned
Alliqua BioMedical Inc.; Human Regenerative Technologies
LLC; Applied Biologics
LLC; DermaSciences; Amniox Medical Inc.; Amnio Technology
LLC; Skye Biologics
Inc.; MiMedx Group Inc.; and Organogensis
Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.